氨基酸与FDG-PET鉴别放疗后脑转移瘤复发与放射性坏死的诊断准确性:系统评价与Meta分析
该系统评价与Meta分析纳入15项研究,评估氨基酸与FDG-PET在随访脑MRI增强病灶中鉴别脑转移瘤复发与放射性坏死的诊断准确性。汇总敏感度0.85、特异度0.88、AUC 0.93,氨基酸与FDG-PET诊断准确性相似,但研究受样本量小、60%为回顾性设计的限制。
要点
- PET鉴别脑转移瘤复发与放射性坏死的汇总敏感度0.85、特异度0.88、AUC 0.93。
- 氨基酸与FDG-PET亚组分析显示两者诊断准确性相似。
- 量化方法(基于病灶与否)对异质性有贡献,P=.07。
核心结论
- 氨基酸与FDG-PET在鉴别放疗后脑转移瘤复发与放射性坏死方面具有良好的诊断准确性。
研究设计与样本
- 系统评价与Meta分析,纳入15项研究,检索PubMed、Embase和Cochrane Library,采用双变量随机效应模型分析,以随访脑MRI增强病灶为参考标准。
诊断标准与关键数值
- PET鉴别脑转移瘤复发与放射性坏死的汇总敏感度0.85、特异度0.88。
- 汇总阳性似然比7.0、阴性似然比0.17、诊断比值比40。
- 汇总受试者工作特征曲线下面积0.93。
- 氨基酸与FDG-PET亚组分析显示诊断准确性相似。
- Meta回归分析显示基于患者、病灶或PET扫描的量化方法(基于病灶与否,P=.07)对异质性有贡献。
临床应用与阅片要点
- 对放疗后脑转移瘤随访MRI增强病灶,PET可用于鉴别肿瘤复发与放射性坏死。
- 氨基酸与FDG-PET均可选用,两者诊断准确性相似。
局限性
- 研究受样本量小的限制。
- 60%的纳入研究为回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Current studies that analyze the usefulness of amino acid and FDG-PET in distinguishing brain metastasis recurrence and radionecrosis after radiation therapy are limited by small cohort size.
PURPOSE: Our aim was to assess the diagnostic accuracy of amino acid and FDG-PET in differentiating brain metastasis recurrence from radionecrosis after radiation therapy.
DATA SOURCES: Studies were retrieved from PubMed, Embase, and the Cochrane Library.
STUDY SELECTION: Fifteen studies were included from the literature. Each study used PET to differentiate radiation necrosis from tumor recurrence in contrast-enhancing lesions on follow-up brain MR imaging after treating brain metastasis with radiation therapy.
DATA ANALYSIS: Data were analyzed with a bivariate random-effects model. Sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were pooled, and a summary receiver operating characteristic curve was fit to the data.
DATA SYNTHESIS: The overall pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio of PET were 0.85, 0.88, 7.0, 0.17, and 40, respectively. The area under the receiver operating characteristic curve was 0.93. On subgroup analysis of different tracers, amino acid and FDG-PET had similar diagnostic accuracy. Meta-regression analysis demonstrated that the method of quantification based on patient, lesion, or PET scan (based on lesion versus not, P = .07) contributed to the heterogeneity.
LIMITATIONS: Our study was limited by small sample size, and 60% of the included studies were of retrospective design.
CONCLUSIONS: Amino acid and FDG-PET had good diagnostic accuracy in differentiating brain metastasis recurrence from radionecrosis after radiation therapy.
引用
- Li H, Deng L, Bai HX, et al. Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol. 2017. PMID: 29242363. doi:10.3174/ajnr.A5472
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。